Liothyronine supplies the active thyroid hormone T3 directly. Correcting a genuine thyroid shortfall is undisputed, and in emergencies its speed can be life-saving. About half of patients prefer T3-containing regimens, and real-world data link them to lower death and dementia rates, yet controlled trials have not confirmed lasting benefit. The main downside is harm from taking too much. (Full Review)

Protocol

Most-Studied Approach

Combination T4 + T3

Keep levothyroxine as the base and add a small amount of liothyronine, T4:T3 dose ratio roughly 13:1 to 20:1.

Starting Dose & Titration

Low & slow

Commonly start around 5 mcg daily, increasing in small increments every 1–2 weeks as tolerated.

Dosing Schedule

Split, morning

Divide the daily dose into 2–3 portions to smooth T3 peaks; taken in the morning, ideally on an empty stomach.

Time to effect

Onset of Action

Within hours

T3 acts within hours; peak blood levels within 2–4 hours of a dose.

Near-Maximal Effect

2–3 days

Near-maximal effect is reached within 2–3 days of a stable dose, with symptomatic and biochemical changes appearing quickly.

Stable Dose

Weeks to months

Finding the right stable dose through titration typically takes several weeks to a few months.

Benefits

High: Correction of T3 deficiency in hypothyroidism; treatment of myxedema coma and severe decompensated hypothyroidism

Medium: Higher patient-reported preference and symptom relief in a subset of patients; possible reduction in long-term mortality and dementia risk

Low: Favorable short-term changes in some metabolic markers

Speculative: Tissue-specific optimization guided by deiodinase genetics

Contraindications

Untreated adrenal insufficiency (Addison disease)

Untreated thyrotoxicosis

Recent heart attack (e.g. <90 days) without specialist oversight

Uncontrolled atrial fibrillation or unstable angina

Severe osteoporosis

Key Interactions

Oral anticoagulants (warfarin)

Antidiabetic drugs (insulin, metformin, sulfonylureas such as glipizide)

Sympathomimetics and stimulants (pseudoephedrine, caffeine)

Tricyclic and related antidepressants

Estrogens (oral contraceptives, hormone replacement)

Absorption-impairing supplements (calcium carbonate, iron, magnesium, aluminum antacids)

Soy and high-fiber supplements

Additive thyroid-raising agents (levothyroxine, desiccated thyroid, biotin)

Risk & Side Effects

High: Symptoms of over-replacement; cardiac effects: arrhythmia and atrial fibrillation risk

Medium: Accelerated bone loss and reduced bone density; unstable blood levels from short half-life

Low: Adverse events from unregulated or compounded products

Speculative: Long-term risks of non-physiological T3 exposure

Monitoring

Marker	Target	Why
TSH (thyroid-stimulating hormone)	≈ 0.5–2.5 mIU/L (avoid full suppression)	Detects over- or under-replacement
Free T3	Mid-to-upper half of reference range	Tracks the active hormone supplied by liothyronine
Free T4	Lower half of reference range on combination therapy	Expected to fall as T3 is added
Reverse T3	Low end of range	Flags impaired conversion / non-active hormone accumulation
Resting heart rate / rhythm	60–80 bpm, regular	Monitors cardiac over-stimulation
Bone mineral density	Age-appropriate, stable over time	Detects accelerated bone loss from over-replacement

Cadence: Recheck thyroid labs at about 6–8 weeks after starting or changing the dose, repeating until stable, then every 6–12 months once a steady dose is reached; draw before the morning dose.

Qualitative Assessment

Energy and fatigue levels through the day
Mental clarity and freedom from "brain fog"
Mood stability
Sleep quality
Cold tolerance and body temperature
Absence of over-replacement signs (palpitations, tremor, anxiety, heat intolerance)

Liothyronine for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment